• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受维持性透析治疗的终末期肾病患者中,I 型前胶原羧基端肽水平升高提示舒张功能障碍。

Increased procollagen type I C-terminal peptide levels indicate diastolic dysfunction in end-stage renal disease patients undergoing maintenance dialysis therapy.

机构信息

Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

J Am Soc Echocardiogr. 2012 Aug;25(8):895-901. doi: 10.1016/j.echo.2012.04.025. Epub 2012 Jun 1.

DOI:10.1016/j.echo.2012.04.025
PMID:22658561
Abstract

BACKGROUND

Cardiac dysfunction is common among patients with end-stage renal disease. The aim of this study was to explore the determinants of diastolic dysfunction in patients with end-stage renal disease on maintenance hemodialysis.

METHODS

Patients with asymptomatic end-stage renal disease undergoing hemodialysis underwent Doppler tissue imaging analysis and two-dimensional speckle-tracking echocardiography with strain analysis. Blood studies included albumin, cardiac troponin T, and procollagen type I C-terminal peptide (PICP).

RESULTS

All enrolled patients had left ventricular (LV) diastolic dysfunction and were stratified into two groups by a cutoff value of 13 for the ratio of early transmitral flow velocity to the average early diastolic annular velocity (E/e'). Seventy-two of the enrolled patients (87%) had grade 1 diastolic dysfunction, and 11 patients (13%) had higher grades of diastolic dysfunction. The study population did not include a representative sample of patients with the pseudonormal or restrictive filling patterns of diastolic dysfunction. There were no significant differences in gender, age, LV geometric change, ejection fraction, global systolic longitudinal strain and strain rate, and prevalence of comorbidities between groups. Patients with average E/e' ≥ 13 had higher PICP, which was significantly correlated with cardiac troponin T, average E/e', and systolic circumferential strain rate. By multivariate regression analysis, average E/e' level was an independent factor of PICP level (P = .047).

CONCLUSIONS

Hemodialysis patients with high average E/e' ratios showed increased levels of LV filling pressure and higher severity levels of cardiac fibrosis, which occurred before the development of systolic dysfunction. PICP was a potential indicator of diastolic dysfunction and increased LV filling pressure.

摘要

背景

心脏功能障碍在终末期肾病患者中很常见。本研究旨在探讨维持性血液透析的终末期肾病患者舒张功能障碍的决定因素。

方法

无症状的终末期肾病行血液透析的患者进行多普勒组织成像分析和二维斑点追踪超声心动图应变分析。血液研究包括白蛋白、心肌肌钙蛋白 T 和前胶原 I C 端肽(PICP)。

结果

所有入组患者均存在左心室(LV)舒张功能障碍,并根据早期二尖瓣血流速度与平均早期舒张环速度比(E/e')的 13 作为截止值将患者分为两组。72 名入组患者(87%)存在 1 级舒张功能障碍,11 名患者(13%)存在更高级别的舒张功能障碍。研究人群不包括舒张功能障碍假性正常或限制性充盈模式的代表性患者样本。两组间的性别、年龄、LV 几何变化、射血分数、整体收缩纵向应变和应变率以及合并症患病率均无显著差异。E/e'平均值≥13 的患者的 PICP 较高,与心肌肌钙蛋白 T、平均 E/e'和收缩周向应变率显著相关。通过多元回归分析,平均 E/e'水平是 PICP 水平的独立因素(P=0.047)。

结论

E/e'比值较高的血液透析患者表现出 LV 充盈压升高和心脏纤维化严重程度增加,这发生在收缩功能障碍之前。PICP 是舒张功能障碍和 LV 充盈压升高的潜在指标。

相似文献

1
Increased procollagen type I C-terminal peptide levels indicate diastolic dysfunction in end-stage renal disease patients undergoing maintenance dialysis therapy.在接受维持性透析治疗的终末期肾病患者中,I 型前胶原羧基端肽水平升高提示舒张功能障碍。
J Am Soc Echocardiogr. 2012 Aug;25(8):895-901. doi: 10.1016/j.echo.2012.04.025. Epub 2012 Jun 1.
2
High-sensitive cardiac troponin T: a biomarker of left-ventricular diastolic dysfunction in hemodialysis patients.高敏心肌肌钙蛋白 T:血液透析患者左心室舒张功能障碍的生物标志物。
J Nephrol. 2018 Dec;31(6):967-973. doi: 10.1007/s40620-018-0540-0. Epub 2018 Oct 22.
3
Associations of tissue Doppler imaging with NT-proBNP and hs-TnT: a pilot study in end-stage renal disease.组织多普勒成像与NT-脑钠肽前体及高敏肌钙蛋白T的相关性:终末期肾病的一项初步研究
Echocardiography. 2014 Nov;31(10):1205-12. doi: 10.1111/echo.12552.
4
A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome.一项关于醛固酮拮抗作用对代谢综合征患者左心室功能、结构和纤维化标志物的有益影响的随机研究。
JACC Cardiovasc Imaging. 2011 Dec;4(12):1239-49. doi: 10.1016/j.jcmg.2011.08.014.
5
Correlation of Left Atrial Strain and Doppler Measurements with Invasive Measurement of Left Ventricular End-Diastolic Pressure in Patients Stratified for Different Values of Ejection Fraction.根据不同射血分数值分层的患者中,左心房应变及多普勒测量值与左心室舒张末期压力有创测量值的相关性。
Echocardiography. 2016 Mar;33(3):398-405. doi: 10.1111/echo.13094. Epub 2015 Oct 23.
6
Integrated backscatter as a fibrosis marker in the metabolic syndrome: association with biochemical evidence of fibrosis and left ventricular dysfunction.整体反向散射作为代谢综合征纤维化的标志物:与纤维化和左心室功能障碍的生化证据相关。
Eur Heart J Cardiovasc Imaging. 2012 Jun;13(6):459-67. doi: 10.1093/ejechocard/jer291. Epub 2011 Dec 20.
7
Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.B 型利钠肽在检测β-地中海贫血症患者隐匿性左心室舒张功能障碍中的预测价值。
Am Heart J. 2010 Jan;159(1):68-74. doi: 10.1016/j.ahj.2009.10.025.
8
Effect of an increase in left ventricular pressure overload on left atrial-left ventricular coupling in patients with hypertension: a two-dimensional speckle tracking echocardiographic study.左心室压力超负荷增加对高血压患者左心房-左心室耦联的影响:一项二维斑点追踪超声心动图研究
Echocardiography. 2013 Jul;30(6):658-66. doi: 10.1111/echo.12117. Epub 2013 Jan 24.
9
Triphasic mitral inflow velocity with mid-diastolic flow: the presence of mid-diastolic mitral annular velocity indicates advanced diastolic dysfunction.伴有舒张中期血流的三相二尖瓣流入速度:舒张中期二尖瓣环速度的存在表明舒张功能障碍进展。
Eur J Echocardiogr. 2006 Jan;7(1):16-21. doi: 10.1016/j.euje.2005.03.007.
10
The N-terminal propeptide of type III procollagen in patients with acute coronary syndrome: a link between left ventricular end-diastolic pressure and cardiovascular events.急性冠状动脉综合征患者III型前胶原氨基端前肽:左心室舒张末期压力与心血管事件之间的联系
PLoS One. 2015 Jan 5;10(1):e114097. doi: 10.1371/journal.pone.0114097. eCollection 2015.

引用本文的文献

1
Connection between Cardiac Fibrosis Biomarkers and Echocardiography Parameters in Advanced Chronic Kidney Disease Patients.晚期慢性肾脏病患者心脏纤维化生物标志物与超声心动图参数之间的关联
J Clin Med. 2023 Apr 20;12(8):3003. doi: 10.3390/jcm12083003.
2
Predictive Value of Collagen Biomarkers in Advanced Chronic Kidney Disease Patients.预测价值的胶原生物标志物在晚期慢性肾脏病患者。
Biomolecules. 2023 Feb 18;13(2):389. doi: 10.3390/biom13020389.
3
Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial.
在血液透析患者中,纤维化、心血管和全因死亡率的血清标志物:AURORA 试验。
Clin Res Cardiol. 2022 Jun;111(6):614-626. doi: 10.1007/s00392-021-01898-9. Epub 2021 Jun 25.
4
Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis.FIBROTARGETS 研究的基本原理旨在确定心肌纤维化的新型生物标志物。
ESC Heart Fail. 2018 Feb;5(1):139-148. doi: 10.1002/ehf2.12218. Epub 2017 Oct 7.
5
Incremental value of global longitudinal strain in prediction of all-cause mortality in predialysis and dialysis chronic kidney disease patients.整体纵向应变在预测透析前及透析慢性肾脏病患者全因死亡率中的增量价值。
Wien Klin Wochenschr. 2016 Jul;128(13-14):495-503. doi: 10.1007/s00508-016-0978-9. Epub 2016 Mar 14.
6
Associations of tissue Doppler imaging with NT-proBNP and hs-TnT: a pilot study in end-stage renal disease.组织多普勒成像与NT-脑钠肽前体及高敏肌钙蛋白T的相关性:终末期肾病的一项初步研究
Echocardiography. 2014 Nov;31(10):1205-12. doi: 10.1111/echo.12552.
7
Elevated serum interleukin-18 level is associated with all-cause mortality in stable hemodialysis patients independently of cardiac dysfunction.血清白细胞介素-18水平升高与稳定期血液透析患者的全因死亡率相关,且独立于心脏功能障碍。
PLoS One. 2014 Mar 5;9(3):e89457. doi: 10.1371/journal.pone.0089457. eCollection 2014.